FDA Approved: DEFERASIROX — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved the original ANDA for a generic deferasirox (DEFERASIROX) from Ascend Laboratories, expanding access to an iron-chelating therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Transfusion-dependent Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)